Multi-purpose, then, perhaps with Big Tech and Big Gov't collaborating. Certainly the 'subscription model' has become de rigeur for all sorts of things, now even with "vaccines."
Multi-purpose, then, perhaps with Big Tech and Big Gov't collaborating. Certainly the 'subscription model' has become de rigeur for all sorts of things, now even with "vaccines."
Multi-purpose, then, perhaps with Big Tech and Big Gov't collaborating. Certainly the 'subscription model' has become de rigeur for all sorts of things, now even with "vaccines."